5 syllables: I, pi, li, mu, mab. Stress on li.
eye-pil-IM-yoo-mab
/aɪ pɪ ˈlɪ mjuː mæb/
Ipilimumab is pronounced eye-pil-IM-yoo-mab (/aɪ pɪ ˈlɪ mjuː mæb/). It has five syllables (I-pi-li-mu-mab), with the stress on "li". Ipilimumab is a monoclonal antibody used in cancer immunotherapy to stimulate the immune system to attack tumors. It targets CTLA-4 to release immune checkpoints, enhancing T-cell responses. As a complex biologic, its name is derived from Latinized chemical naming conventions rather than everyday language.
nounIpilimumab is a monoclonal antibody used in cancer immunotherapy to stimulate the immune system to attack tumors. It targets CTLA-4 to release immune checkpoints, enhancing T-cell responses. As a complex biologic, its name is derived from Latinized chemical naming conventions rather than everyday language.
"The clinical trial evaluated the efficacy of ipilimumab in advanced melanoma."
"Oncologists administer ipilimumab as part of combination regimens in some cases."
"Patients receiving ipilimumab are monitored for immune-related adverse events."
Pronounce as I-PIL-i-MYU-mab, with primary stress on the third syllable: i-pi-LI-mu-mab. IPA: US ˌaɪ.pɪˈlɪm.ju.mæb; UK ˌaɪ.pɪˈlɪm.juː.mæb; AU ˌaɪ.pɪˈlɪm.juː.mæb. Break it into five syllables: i-pi-li-mu-mab, placing emphasis on li-MYU (second–third syllable). The final -mab is pronounced as mab, not ‘mabb’ and the ‘ab’ ends with a soft ‘b’ sound. Visualize saying “eye-pill-ih-MYOO-mab” for US/UK vowel quality, then adjust toward AU’s longer vowel in the middle syllable.
Common errors: (1) Dropping syllables, saying ‘ipili-mab’ or ‘ipili-mab’ with reduced vowels. (2) Misplacing stress, often stressing the wrong syllable, leading to ‘IP-i-li-MU-mab’. (3) Vowel mergers in the middle: treating ‘li’ and ‘mu’ as a single reduced vowel sequence. Corrections: repeat the five-syllable chain slowly, mark the primary stress on LI or LI- in LI-MYU, and practice with a clock-timed shadowning routine to solidify the stress pattern and vowel lengths.
US tends to produce a sharper /ju/ in the second-to-last syllable and a rhotacized ‘r’-like influence in connected speech. UK often has a tighter, shorter final vowels and a longer mid vowel in the second schwa-like segment; AU can show a slightly rounded ‘u’ in the MYOO segment and a more even vowel length across syllables. IPA references: US ˌaɪ.pɪˈlɪm.ju.mæb; UK ˌaɪ.pɪˈlɪm.juː.mæb; AU ˌaɪ.pɪˈlɪm.juː.mæb. All share the five-syllable pattern, but vowel qualities shift slightly with rhoticity and non-rhotic tendencies in UK.
It’s the multi-syllabic sequence and the unfamiliar consonant cluster at the tail end. The ‘-mab’ suffix is easy to mispronounce as ‘-mbab’ or shorten the word by dropping middle syllables. The presence of the ‘li’ and ‘ju’ sequences together can create IPA-level ambiguity for non-medical speakers. Focus on the five distinct syllables, maintain equal syllable timing, and keep the jaw relaxed to avoid a rushed, clipped final ‘mab’.
A unique aspect is the careful articulation of ‘ju’ in the penultimate syllable, which represents a near-yu sound in many accents. Practicing with minimal pairs like ‘mab’ vs ‘mube’ helps isolate the final syllable’s short vowel, preventing vowel lengthening that alters the ending. Remember to start with a clear /ju/ sequence before the final /mab/.
🗣️ Voice search tip: These questions are optimized for voice search. Try asking your voice assistant any of these questions about "Ipilimumab"!
Ipilimumab derives from chemical and biologic nomenclature rather than a traditional linguistic root. The prefix ‘-ipili-’ aligns with systematic components used in naming monoclonal antibodies, with the suffix ‘-mab’ indicating a monoclonal antibody. The ‘ipi-’ portion does not carry a semantic meaning in isolation; rather, it is a contracted sequence resulting from the combinatorial process researchers use to denote antibody constructs and their binding domains. The string ‘limu’ does not correspond to a dictionary root but helps distinguish this antibody’s target or lineage within the IL-2/CTLA-4/immune signaling space during development. First approved in the 2010s for oncologic indications, ipilimumab’s name has become synonymous with immune checkpoint blockade in oncology, reflecting its mechanism (CTLA-4 inhibition) rather than a descriptive clinical term. Over time, the object’s pharmacological identity has eclipsed its linguistic origin, with “ipilimumab” recognized globally as a specific therapeutic antibody. In usage, the word is pronounced with particular emphasis on the syllables that reflect its constructed, non-lexical root rather than a natural language root, which is common for modern biologic agents.
💡 Etymology tip: Understanding word origins can help you remember pronunciation patterns and recognize related words in the same language family.
Help others use "Ipilimumab" correctly by contributing grammar tips, common mistakes, and context guidance.
💡 These words have similar meanings to "Ipilimumab" and can often be used interchangeably.
🔄 These words have opposite meanings to "Ipilimumab" and show contrast in usage.
📚 Vocabulary tip: Learning synonyms and antonyms helps you understand nuanced differences in meaning and improves your word choice in speaking and writing.
Words that rhyme with "Ipilimumab"
Practice with these rhyming pairs to improve your pronunciation consistency:
🎵 Rhyme tip: Practicing with rhyming words helps you master similar sound patterns and improves your overall pronunciation accuracy.
